Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Dementia Study in Northern Norway

This study has been completed.
County Officer of Nordland, Moloveien 2, 8006 Bodø, Norway
Norwegian Foundation for Health and Rehabilitation
Norwegian Department of Health and Social Affairs
Information provided by (Responsible Party):
University Hospital of North Norway Identifier:
First received: March 2, 2007
Last updated: November 9, 2011
Last verified: November 2011

The Dementia Study in Northern Norway is an open controled intervention trial carried out in nine rural municipalities, five of which allocated to intervention and four to control. A RCT with donepezil and placebo is superimposed on all patients included in the study. In this way the study has a 2x2 factorial design. The outcome measures are changes in cognitive performance and ADL function measured by standardized cognitive and neuropsychological tests every four months during a one-year follow-up.

The main goal of this study is to examine the effect of systematically and individually adjusted stimulation therapy on cognitive function in patients having recent diagnoses of Alzheimer´s disease (AD).

A secondary goal is to examine whether or not ChEI has an additional effect on cognitive function superimposed on stimulation therapy.

From January 2006 to 31th March 2008 187 patients with a recent diagnosis of dementia were included. Patients were recruited by GPs in routine practice (n=87) and by a population based screening (n=100).Screening recruited younger patients with a higher MMSE-score, and relatively more men. All over, women were older and at a more serious disease stage. After age adjusting significantly more women were living single and required more supports from the community nursery.

Condition Intervention Phase
Alzheimer Disease
Device: Cognitive, physical and social stimulation
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Phase 4 Study of Cognitive Therapy and Donepezil in Alzheimers Disease.

Resource links provided by NLM:

Further study details as provided by University Hospital of North Norway:

Primary Outcome Measures:
  • The cognitive function is measured with the Alzheimer's Disease Assessment [ Time Frame: Every fourth month in one year ]

Secondary Outcome Measures:
  • Changes in Activity of Daily Living (ADL) measured by standardized tests. [ Time Frame: When the patient is included and after one year ]

Enrollment: 187
Study Start Date: June 2003
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: A Cognitive stimulation therapy
Patients with recently diagnosed dementia in five of the study municipality.
Device: Cognitive, physical and social stimulation
Sessions of 30 minutes daily five days a week for one year
No Intervention: B Care as usual

  Show Detailed Description


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Subject aged 65-94 years with a recent diagnosed AD and without any contraindications for the use of donepezil.
  • A MMSE sum score has to be at least10 points

Exclusion Criteria:

  • Behavioural disturbance which make cooperation and cognitive testing impossible.
  • Individuals with reduced approval competence expressing any reluctance to participate are excluded, as well as those not understanding the purpose of the study and who have relatives or care givers disapproving participation.
  • Individuals having a diagnosis of dementia treated with CheI at entry are also excluded.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00443014

Arran Lulesami Centre
Drag, Nordland, Norway, 8270
Sponsors and Collaborators
University Hospital of North Norway
County Officer of Nordland, Moloveien 2, 8006 Bodø, Norway
Norwegian Foundation for Health and Rehabilitation
Norwegian Department of Health and Social Affairs
Principal Investigator: Fred Andersen, MD GP University of Northern Norway
Study Director: Torgeir Engstad, MD, PhD University of Northern Norway
  More Information

Additional Information:
Graff, M J L et al. Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial. BMJ 2006;333:1196 (9 December), doi:10.1136/bmj.39001.688843.BE Editorials. Treatment of dementia in the community. BMJ 2006;333:1184-1185 (9 December), doi:10.1136/bmj.39051.484421.80

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: University Hospital of North Norway Identifier: NCT00443014     History of Changes
Other Study ID Numbers: 200201054-12/12BMA2/400
Study First Received: March 2, 2007
Last Updated: November 9, 2011

Keywords provided by University Hospital of North Norway:
Stimulation therapy
Acetylcholinesterase inhibitors

Additional relevant MeSH terms:
Alzheimer Disease
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders processed this record on April 28, 2017